Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants
Olena Anoshchenko(Gilead Sciences (United States)), Rita Humeniuk(Gilead Sciences (United States)), Mazin Abdelghany(University of California, San Francisco), Deqing Xiao(Gilead Sciences (United States)), Ran Duan(Taiyuan Maternity and Child Care Hospital), Heng Chen(Gilead Sciences (United States)), Amos Lichtman(Gilead Sciences (United States)), R. Hyland(Gilead Sciences (United States)), Helen Winter(Hackensack University Medical Center), Luzelena Caro(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joe Llewellyn(Gilead Sciences (United States)), Keelin Castellanos(Gilead Sciences (United States)), Lily Mak(Gilead Sciences (United States)), Qin Yue(Gilead Sciences (United States)), Santosh Davies(Gilead Sciences (United States)), Abdul Naveed Shaik(Gilead Sciences (United States)), Chi‐Chi Peng(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States))
Cited by 12
Related Papers
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Comparison of Information-Dependent Acquisition, SWATH, and MS<sup>All</sup> Techniques in Metabolite Identification Study Employing Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry
|Analytical Chemistry|2013|211
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
|The Lancet Oncology|2023|195
Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry
|Journal of Mass Spectrometry|2006|153